Clinical Trials Directory

Trials / Unknown

UnknownNCT05093660

Diagnostic Importance of the Circulating Human Leucine-rich α-2-glycoprotein in Acute Appendicitis in Pediatric Patients

Diagnostic Importance of the Circulating Human Leucine-rich α-2-glycoprotein Analysed From Blood and Saliva in Children With Acute Appendicitis

Status
Unknown
Phase
Study type
Observational
Enrollment
90 (estimated)
Sponsor
KBC Split · Academic / Other
Sex
All
Age
5 Years – 17 Years
Healthy volunteers
Not accepted

Summary

Acute appendicitis is a common and potentially serious medical condition which can be difficult to diagnose, especially in pediatric patients. To help recognize patients with acute appendicitis, number of laboratory and radiological test are used. Previous research has shown that Circulating Human Leucine-rich α-2-glycoprotein (LGR1) in the blood can be elevated in pediatric patients with acute appendicitis. The aim of this research is to analyse whether LGR1 levels in saliva can be used as a less invasive diagnostic method in pediatric patients with suspected acute appendicitis.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTBlood specimen collectionBlood specimen collection for analysis of CRP (C-reactive protein), WBC (White blood cells) and LRG1 (Circulating Human Leucine-rich α-2-glycoprotein) levels
DIAGNOSTIC_TESTSaliva specimen collectionSaliva specimen collection for analysis of LRG1 (Circulating Human Leucine-rich α-2-glycoprotein) levels

Timeline

Start date
2021-10-15
Primary completion
2022-06-30
Completion
2022-06-30
First posted
2021-10-26
Last updated
2022-04-07

Locations

1 site across 1 country: Croatia

Source: ClinicalTrials.gov record NCT05093660. Inclusion in this directory is not an endorsement.

Diagnostic Importance of the Circulating Human Leucine-rich α-2-glycoprotein in Acute Appendicitis in Pediatric Patients (NCT05093660) · Clinical Trials Directory